DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/7c51d8/autoimmune_disease) has announced the addition of the "Autoimmune Disease Therapeutics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns Disease (Biologics), and Others. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.The report profiles 112 companies including many key and niche players such as Abbott Laboratories, Amgen Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Elan Corporation, plc, Eli Lilly And Company, F. Hoffmann-La Roche AG, Chugai Pharmaceutical Co., Ltd., Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck & Co., Inc, Merck Serono SA, Novartis AG, Sanofi-aventis SA , Shire Plc, Teva Pharmaceuticals Industries Limited, and UCB S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Key Topics Covered:
1. Introduction, Methodology & Product Definitions 2. Industry Overview & Outlook 3. Market Dynamics and Trends 4. Disease Overview 5. Overview of Select Autoimmune Diseases 6. Clinical Trials & Research Studies 7. Product Introductions/Approvals 8. Product Innovations/Introductions in the Recent Past - a Perspective Builder 9. Recent Industry Activity 10. Corporate Activity in the Recent Past - a Perspective Builder 11. Focus on Select Global Players 12. Global Market Perspective 13. the United States 14. Japan 15. Europe 16. Rest of World
Companies Mentioned:
- Abbott Laboratories
- Amgen Inc.
- Bayer Schering Pharma AG
- Biogen Idec Inc.
- Bristol-Myers Squibb Company
- Elan Corporation plc
- Eli Lilly And Company
- F. Hoffmann-La Roche AG
- Chugai Pharmaceutical Co. Ltd.
- Genentech Inc.
- GlaxoSmithKline plc
- Johnson & Johnson Inc.
- Merck & Co.Inc
- Merck Serono SA
- Novartis AG
- Sanofi-aventis SA
- Shire Plc
- Teva Pharmaceuticals Industries Limited
- UCB S.A.
For more information visit http://www.researchandmarkets.com/research/7c51d8/autoimmune_disease